Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The U.K. regulator is the third regulatory authority to license the medicine as the Danish drugmaker seeks to regain its lead in the obesity market. on.wsj.com/4uvBZC6
https://on.wsj.com/4uvBZC6
2026-06-11T15:44:27.567Z